Literature DB >> 28161918

Bowled Over by Cricket: Impact of Tape-Ball Injuries on the Eyes.

Salman Naveed Sadiq1, Azam Ali1, Bushra Usmani1, Khabir Ahmad1.   

Abstract

PURPOSE: The aim of this study was to describe the type and severity of tape-ball cricket-related eye injuries seen at a tertiary care hospital.
DESIGN: A descriptive case series.
METHODS: This study included all cases of tape-ball cricket-related eye injuries presenting to the Section of Ophthalmology, Aga Khan University Hospital, Karachi, from January 2014 to January 2015.
RESULTS: A total of 20 patients with tape-ball cricket-related eye injuries were treated during this period. The right eye was involved in most (14/20) of the cases. The commonest presenting symptoms included reduced/blurred vision, ocular pain, redness, and floaters. Sixty percent (12/20) of the affected eyes had a best corrected visual acuity of less than 20/200 at presentation, with the retina being the most commonly involved ocular structure. All patients reported that they were not wearing protective eyewear at the time of trauma. Despite standard management, half of the eyes had severe or total vision loss at the last follow-up (minimum, 3 months), mainly due to retinal damage.
CONCLUSIONS: Our study calls for the compulsory use of protective eyewear by cricket players and for countrywide surveillance data on the true burden of this "unnoticed" preventable cause of unilateral eye injuries and associated vision loss. Copyright
© 2017 Asia-Pacific Academy of Ophthalmology.

Entities:  

Keywords:  blindness; blunt trauma; cricket; eye injuries; preventable injury; protective eyewear; tape ball

Mesh:

Year:  2017        PMID: 28161918     DOI: 10.1097/APO.0000000000000202

Source DB:  PubMed          Journal:  Asia Pac J Ophthalmol (Phila)        ISSN: 2162-0989


  1 in total

1.  A 3-year prospective study on ocular injuries with tennis or cricket ball while playing cricket: A case series.

Authors:  Santosh Kumar Mahapatra; Kundan Malhotra; Rohit Ganapatrao Mendke
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.